These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 30123578)

  • 41. Off-the-shelf tissue engineered heart valves for in situ regeneration: current state, challenges and future directions.
    Motta SE; Lintas V; Fioretta ES; Hoerstrup SP; Emmert MY
    Expert Rev Med Devices; 2018 Jan; 15(1):35-45. PubMed ID: 29257706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histologic Evaluation of Explanted Tissue-Engineered Bovine Pericardium (CardioCel).
    Prabhu S; Armes JE; Bell D; Justo R; Venugopal P; Karl T; Alphonso N
    Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):356-363. PubMed ID: 29195576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A sterilization method for decellularized xenogeneic cardiovascular scaffolds.
    Fidalgo C; Iop L; Sciro M; Harder M; Mavrilas D; Korossis S; Bagno A; Palù G; Aguiari P; Gerosa G
    Acta Biomater; 2018 Feb; 67():282-294. PubMed ID: 29183849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcific Degeneration of CorMatrix 4 Years After Bicuspidization of Unicuspid Aortic Valve.
    Mosala Nezhad Z; Baldin P; Poncelet A; El Khoury G
    Ann Thorac Surg; 2017 Dec; 104(6):e431-e433. PubMed ID: 29153811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparing the Host Reaction to CorMatrix and Different Cardiac Patch Materials Implanted Subcutaneously in Growing Pigs.
    Mosala Nezhad Z; Poncelet A; Fervaille C; Gianello P
    Thorac Cardiovasc Surg; 2019 Jan; 67(1):44-49. PubMed ID: 29078233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myocardial regenerative therapy using a scaffold-free skeletal-muscle-derived cell sheet in patients with dilated cardiomyopathy even under a left ventricular assist device: a safety and feasibility study.
    Yoshikawa Y; Miyagawa S; Toda K; Saito A; Sakata Y; Sawa Y
    Surg Today; 2018 Feb; 48(2):200-210. PubMed ID: 28821963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced Therapeutic Effects of Human iPS Cell Derived-Cardiomyocyte by Combined Cell-Sheets with Omental Flap Technique in Porcine Ischemic Cardiomyopathy Model.
    Kawamura M; Miyagawa S; Fukushima S; Saito A; Miki K; Funakoshi S; Yoshida Y; Yamanaka S; Shimizu T; Okano T; Daimon T; Toda K; Sawa Y
    Sci Rep; 2017 Aug; 7(1):8824. PubMed ID: 28821761
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of extracellular matrix on engraftment and maturation of pluripotent stem cell-derived cardiomyocytes in a rat myocardial infarct model.
    Ogasawara T; Okano S; Ichimura H; Kadota S; Tanaka Y; Minami I; Uesugi M; Wada Y; Saito N; Okada K; Kuwahara K; Shiba Y
    Sci Rep; 2017 Aug; 7(1):8630. PubMed ID: 28819182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter Double-Blind Controlled CAREMI Trial (Cardiac Stem Cells in Patients With Acute Myocardial Infarction).
    Sanz-Ruiz R; Casado Plasencia A; Borlado LR; Fernández-Santos ME; Al-Daccak R; Claus P; Palacios I; Sádaba R; Charron D; Bogaert J; Mulet M; Yotti R; Gilaberte I; Bernad A; Bermejo J; Janssens S; Fernández-Avilés F
    Circ Res; 2017 Jun; 121(1):71-80. PubMed ID: 28533209
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differentiation of cardiomyocytes and generation of human engineered heart tissue.
    Breckwoldt K; Letuffe-Brenière D; Mannhardt I; Schulze T; Ulmer B; Werner T; Benzin A; Klampe B; Reinsch MC; Laufer S; Shibamiya A; Prondzynski M; Mearini G; Schade D; Fuchs S; Neuber C; Krämer E; Saleem U; Schulze ML; Rodriguez ML; Eschenhagen T; Hansen A
    Nat Protoc; 2017 Jun; 12(6):1177-1197. PubMed ID: 28492526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase I Clinical Trial of Autologous Stem Cell-Sheet Transplantation Therapy for Treating Cardiomyopathy.
    Miyagawa S; Domae K; Yoshikawa Y; Fukushima S; Nakamura T; Saito A; Sakata Y; Hamada S; Toda K; Pak K; Takeuchi M; Sawa Y
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28381469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decellularized Cryopreserved Allografts as Off-the-Shelf Allogeneic Alternative for Heart Valve Replacement: In Vitro Assessment Before Clinical Translation.
    Iop L; Paolin A; Aguiari P; Trojan D; Cogliati E; Gerosa G
    J Cardiovasc Transl Res; 2017 Apr; 10(2):93-103. PubMed ID: 28281241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro comparative assessment of decellularized bovine pericardial patches and commercial bioprosthetic heart valves.
    Aguiari P; Iop L; Favaretto F; Fidalgo CM; Naso F; Milan G; Vindigni V; Spina M; Bassetto F; Bagno A; Vettor R; Gerosa G
    Biomed Mater; 2017 Feb; 12(1):015021. PubMed ID: 28157718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intracoronary Cardiac Progenitor Cells in Single Ventricle Physiology: The PERSEUS (Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease) Randomized Phase 2 Trial.
    Ishigami S; Ohtsuki S; Eitoku T; Ousaka D; Kondo M; Kurita Y; Hirai K; Fukushima Y; Baba K; Goto T; Horio N; Kobayashi J; Kuroko Y; Kotani Y; Arai S; Iwasaki T; Sato S; Kasahara S; Sano S; Oh H
    Circ Res; 2017 Mar; 120(7):1162-1173. PubMed ID: 28052915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of the CardioCel bovine pericardial patch - a preliminary report.
    Sobieraj M; Cudak E; Mrówczyński W; Nałęcz TK; Westerski P; Wojtalik M
    Kardiochir Torakochirurgia Pol; 2016 Sep; 13(3):210-212. PubMed ID: 27785133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of immunogenic Neu5Gc in bioprosthetic heart valves.
    Reuven EM; Leviatan Ben-Arye S; Marshanski T; Breimer ME; Yu H; Fellah-Hebia I; Roussel JC; Costa C; Galiñanes M; Mañez R; Le Tourneau T; Soulillou JP; Cozzi E; Chen X; Padler-Karavani V
    Xenotransplantation; 2016 Sep; 23(5):381-92. PubMed ID: 27610947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design.
    Chakravarty T; Makkar RR; Ascheim DD; Traverse JH; Schatz R; DeMaria A; Francis GS; Povsic TJ; Smith RR; Lima JA; Pogoda JM; Marbán L; Henry TD
    Cell Transplant; 2017 Feb; 26(2):205-214. PubMed ID: 27543900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.
    Rao SV; Zeymer U; Douglas PS; Al-Khalidi H; White JA; Liu J; Levy H; Guetta V; Gibson CM; Tanguay JF; Vermeersch P; Roncalli J; Kasprzak JD; Henry TD; Frey N; Kracoff O; Traverse JH; Chew DP; Lopez-Sendon J; Heyrman R; Krucoff MW
    J Am Coll Cardiol; 2016 Aug; 68(7):715-23. PubMed ID: 27515331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials.
    Lawson JH; Glickman MH; Ilzecki M; Jakimowicz T; Jaroszynski A; Peden EK; Pilgrim AJ; Prichard HL; Guziewicz M; Przywara S; Szmidt J; Turek J; Witkiewicz W; Zapotoczny N; Zubilewicz T; Niklason LE
    Lancet; 2016 May; 387(10032):2026-34. PubMed ID: 27203778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decellularized aortic conduits: could their cryopreservation affect post-implantation outcomes? A morpho-functional study on porcine homografts.
    Gallo M; Bonetti A; Poser H; Naso F; Bottio T; Bianco R; Paolin A; Franci P; Busetto R; Frigo AC; Buratto E; Spina M; Marchini M; Ortolani F; Iop L; Gerosa G
    Heart Vessels; 2016 Nov; 31(11):1862-1873. PubMed ID: 27115146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.